30 results on '"Pfister Marc"'
Search Results
2. Understanding Urea Kinetic Factors That Enhance Personalized Hemodialysis Prescription in Children
3. Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers
4. Exploratory Literature Meta‐Analysis to Characterize the Relationship Between Early and Longer Term Body Weight Loss for Antiobesity Compounds
5. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates
6. Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children
7. Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
8. The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus
9. Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics
10. Optimizing Drug Development and Use in Patients With Kidney Disease
11. Defining the Future of Pharmacometrics: The American Society of Pharmacometrics
12. Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development
13. Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development
14. Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism-Based Model Characterizing Sodium-Glucose Cotransporter-2 Inhibition
15. ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics
16. Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry
17. AN INNOVATIVE APPROACH TO ASSOCIATE OUTCOMES RELATED TO ADHERENCE WITH PATIENT BEHAVIORS AND TREATMENT CHARACTERISTICS: P-721
18. Importance of Characterizing Determinants of Variability in Exposure: Application to Dasatinib in Subjects With Chronic Myeloid Leukemia
19. Application of individualized bayesian urea kinetic modeling (IBUKM) to pediatric hemodialysis.: 119
20. Pooled Population PK Modeling for Dapagliflozin. in Patients with Type 2 Diabetes Mellitus: 70
21. APIXABAN DOSE SELECTION FOR DVT PREVENTION IN ELECTIVE TOTAL KNEE REPLACEMENT SURGERY USING EXPOSURE-CLINICAL OUTCOME MODELING.: 75
22. TRIAL SIMULATION-BASED OPTIMAL SAMPLING DESIGNS FOR APIXABAN PHASE III STUDIES: 74
23. Eiposurc-Efficacy Outcome Modeling far Danagliflozin, An Orally Selective SGLT2 Inhibitor, In Patients With Type 2 Diabetes Mellitus: 69
24. Modeling and Simulation of Abatacept Exposure and Interleukin-6 Response in Support of Recommended Doses for Rheumatoid Arthritis
25. Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy
26. Pharmacodynamic Analysis of the Microbiological Efficacy of Telithromycin in Patients with Community-Acquired Pneumonia
27. Optimizing Dose Selection with Modeling and Simulation: Application to the Vasopeptidase Inhibitor M100240
28. Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir
29. Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women
30. Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.